IP Library Granted Patent US 9,283,252
Granted Patent B2
US 9,283,252 · App. 13/119,382 · Granted Mar 15, 2016

Lactic acid bacterium having high oxalic acid decomposition ability

Inventors: Daisuke Ochi (Kanagawa, JP); Hiroshi Tsuboi (Kanagawa, JP)
Assignee: Meiji Co., Ltd.
A61K35/74A23L1/3014C12R1/225A23V2002/00A23Y2220/37
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,283,252
App. No.
13/119,382
Granted
Mar 15, 2016
Kind
B2
Abstract

The present invention provides lactic acid bacteria having oxalic acid-degrading activity several times higher than those of conventionally known lactic acid bacteria having an oxalic acid-degrading activity, and uses thereof. Lactic acid bacteria capable of degrading a large amount of oxalic acid were screened from 132 strains of Lactobacillus lactic acid bacteria that have been independently isolated from feces and gastric juices of human adults. As a result, lactic acid bacteria having an oxalic acid degradation rate of 50% or more when cultured at 37° C. for 72 hours in a culture medium containing 10 mM oxalic acid at pH 6.5 at the start of culture were discovered.

Claims (2)

1. A composition comprising a lactic acid bacterium belonging to the genus Lactobacillus in an amount effective for treating renal/urinary calculus and a component selected from the group consisting of light anhydrous silicic acid, lactose, crystalline cellulose, mannitol, starch, calcium carmellose, sodium carmellose, hydroxypropylcellulose, hydroxypropylmethylcellulose, polyvinylacetal diethylaminoacetate, polyvinylpyrrolidone, gelatin, polyoxyethylene hydrogenated castor oil 60, sucrose, carboxymethylcellulose, and corn starch, wherein the lactic acid bacterium is the Lactobacillus gasseri OLL2727 strain, deposited under Accession No. FERM BP-11004.

2. The composition of claim 1 , which is a pharmaceutical composition or food composition.

Assignments (2)
CHANGE OF NAME Recorded Mar 10, 2012
From: MEIJI DAIRIES CORPORATION
To: MEIJI CO., LTD.
Reel/Frame 027840/0527 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2012
From: OCHI, DAISUKE; TSUBOI, HIROSHI
To: MEIJI CO., LTD.
Reel/Frame 027715/0820 →
Priority Claims (1)
JP 2008-254975 · Sep 30, 2008 · national
Continuity (1)
Related Publication 20110236360A1 · Sep 29, 2011